{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:41Z","timestamp":1791262421351,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515220165"],"award-info":[{"award-number":["2023A1515220165"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20240813115905008"],"award-info":[{"award-number":["JCYJ20240813115905008"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KCXFZ20211020163407011"],"award-info":[{"award-number":["KCXFZ20211020163407011"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20230807095802005"],"award-info":[{"award-number":["JCYJ20230807095802005"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20210324110402006"],"award-info":[{"award-number":["JCYJ20210324110402006"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103130"],"award-info":[{"award-number":["82103130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202211039"],"award-info":[{"award-number":["SZSM202211039"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117522","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:50:58Z","timestamp":1762534258000},"page":"117522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["USP7 inhibitor P5091 enhances the antitumor efficacy of vemurafenib in BRAFV600E-mutant thyroid cancer via ferroptosis"],"prefix":"10.1016","volume":"243","author":[{"given":"Chenchen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117522_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Can. J. Clin."},{"key":"10.1016\/j.bcp.2025.117522_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115173","article-title":"Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies","volume":"26","author":"Forma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117522_b0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Can."},{"key":"10.1016\/j.bcp.2025.117522_b0020","first-page":"1","article-title":"Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification. Methods in Molecular Biology (Clifton","volume":"2534","author":"Lam","year":"2022","journal-title":"N.J.)"},{"key":"10.1016\/j.bcp.2025.117522_b0025","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1111\/jcmm.17443","article-title":"BRAF V600E protect from cell death via inhibition of the mitochondrial permeability transition in papillary and anaplastic thyroid cancers","volume":"26","author":"Gao","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2025.117522_b0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/15384047.2018.1480289","article-title":"Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations","volume":"19","author":"Dovrat","year":"2018","journal-title":"Can. Biol. Ther."},{"key":"10.1016\/j.bcp.2025.117522_b0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/biology12040608","article-title":"Secretome screening of BRAFV600E-mutated colon cancer cells resistant to vemurafenib","volume":"12","author":"Car","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bcp.2025.117522_b0040","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.18632\/oncotarget.9023","article-title":"Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model","volume":"7","author":"Danysh","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117522_b0045","first-page":"6763","article-title":"EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines","volume":"15","author":"Jia","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2025.117522_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091388","article-title":"BRAF inhibitors in thyroid cancer: clinical impact, mechanisms of resistance and future perspectives","volume":"11","author":"Crispo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117522_b0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol Metab (seoul)"},{"key":"10.1016\/j.bcp.2025.117522_b0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1541-7786.MCR-21-0832","article-title":"Activation of the JAK\/STAT pathway leads to BRAF inhibitor resistance in BRAFV600E positive thyroid carcinoma","volume":"21","author":"Limberg","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117522_b0065","doi-asserted-by":"crossref","first-page":"1076640","DOI":"10.3389\/fendo.2023.1076640","article-title":"STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma","volume":"14","author":"He","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117522_b0070","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117522_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106148","article-title":"Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming","volume":"178","author":"Chang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117522_b0080","doi-asserted-by":"crossref","first-page":"34289","DOI":"10.18632\/oncotarget.26136","article-title":"Molecular dynamics simulation reveals the possible druggable hot-spots of USP7","volume":"9","author":"Srivastava","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117522_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/CBM-200052","article-title":"USP7 promotes hepatoblastoma progression through activation of PI3K\/AKT signaling pathway","volume":"31","author":"Ye","year":"2021","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.bcp.2025.117522_b0090","doi-asserted-by":"crossref","first-page":"111037","DOI":"10.1016\/j.mce.2020.111037","article-title":"USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57KIP2 repression","volume":"518","author":"Xie","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117522_b0095","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.27682","article-title":"Ubiquitin\u2010specific protease 7 accelerates p14ARF degradation by deubiquitinating thyroid hormone receptor\u2010interacting protein 12 and promotes hepatocellular carcinoma progression","volume":"61","author":"Cai","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2025.117522_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mc.22905","article-title":"Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA\u2010mediated apoptosis","volume":"58","author":"Hu","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2025.117522_b0105","article-title":"Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting stearoyl-CoA desaturase","volume":"11","author":"Guan","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bcp.2025.117522_b0110","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/s41388-022-02403-w","article-title":"The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1","volume":"41","author":"Gao","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117522_b0115","doi-asserted-by":"crossref","first-page":"11690","DOI":"10.12998\/wjcc.v10.i32.11690","article-title":"Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment","volume":"10","author":"Huang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.bcp.2025.117522_b0120","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1074\/jbc.RA119.010724","article-title":"The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival","volume":"295","author":"He","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117522_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2016.06.015","article-title":"USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs","volume":"107","author":"Malapelle","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2025.117522_b0130","doi-asserted-by":"crossref","first-page":"31815","DOI":"10.18632\/oncotarget.16463","article-title":"The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells","volume":"8","author":"Morra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117522_b0135","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/clinem\/dgab020","article-title":"Organoid cultures derived from patients with papillary thyroid cancer","volume":"106","author":"Chen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2025.117522_b0140","doi-asserted-by":"crossref","first-page":"1140888","DOI":"10.3389\/fendo.2023.1140888","article-title":"Establishment of papillary thyroid cancer organoid lines from clinical specimens","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bcp.2025.117522_b0145","doi-asserted-by":"crossref","first-page":"216587","DOI":"10.1016\/j.canlet.2023.216587","article-title":"USP7-mediated ER\u03b2 stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma","volume":"582","author":"Meng","year":"2024","journal-title":"Can. Lett."},{"key":"10.1016\/j.bcp.2025.117522_b0150","doi-asserted-by":"crossref","first-page":"119766","DOI":"10.1016\/j.bbamcr.2024.119766","article-title":"Wnt\/\u03b2-catenin signaling inhibits oxidative stress-induced ferroptosis to improve interstitial cystitis\/bladder pain syndrome by reducing NF-\u03baB","volume":"1871","author":"Fang","year":"2024","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2025.117522_b0155","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","article-title":"Molecular pathways and mechanisms of BRAF in cancer therapy","volume":"28","author":"Poulikakos","year":"2022","journal-title":"Clin. Can. Res."},{"key":"10.1016\/j.bcp.2025.117522_b0160","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s11864-022-01006-7","article-title":"BRAF inhibitor resistance in melanoma: mechanisms and alternative therapeutic strategies","volume":"23","author":"Zhong","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.bcp.2025.117522_b0165","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur. J. Can."},{"key":"10.1016\/j.bcp.2025.117522_b0170","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF -mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117522_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trecan.2020.05.009","article-title":"Clinical development of BRAF plus MEK inhibitor combinations","volume":"6","author":"Subbiah","year":"2020","journal-title":"Trends in Can"},{"key":"10.1016\/j.bcp.2025.117522_b0180","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-022-05136-6","article-title":"USP7 regulates the ERK1\/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma","volume":"13","author":"Park","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bcp.2025.117522_b0185","doi-asserted-by":"crossref","first-page":"114917","DOI":"10.1016\/j.celrep.2024.114917","article-title":"USP7 deubiquitinates KRAS and promotes non-small cell lung cancer","volume":"43","author":"Huang","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.bcp.2025.117522_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-022-03848-z","article-title":"Papillary thyroid cancer organoids harboring BRAF(V600E) mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117522_b0195","first-page":"257","article-title":"Advances in development and application of human organoids. 3","volume":"11","author":"Shankaran","year":"2021","journal-title":"Biotech"},{"key":"10.1016\/j.bcp.2025.117522_b0200","unstructured":"U.S. Food and Drug Administration. Zelboraf (vemurafenib) prescribing information. 2011. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm (Oct 30, 2025)."},{"key":"10.1016\/j.bcp.2025.117522_b0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/OTT.S182806","article-title":"Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy","volume":"12","author":"Fu","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.bcp.2025.117522_b0210","first-page":"508","article-title":"USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4","volume":"21","author":"Pan","year":"2021","journal-title":"Can. Cell Int."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:21:34Z","timestamp":1781065294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S0006295225007877"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117522","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP7 inhibitor P5091 enhances the antitumor efficacy of vemurafenib in BRAFV600E-mutant thyroid cancer via ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117522"}}